DCX Systems: IPO Proceeds Utilization Report for Q1 FY27

DCX Systems Ltd has submitted its Monitoring Agency Report for the quarter ended June 30, 2026, prepared by CARE Ratings Limited. The report addresses the utilization of proceeds from its Initial Public Offering (IPO) and Qualified Institutional Placement (QIP). The company confirms no deviation from the stated objects of the issue. However, there was a change in the allocation within the specified objects, requiring shareholder approval. Notably, the purpose of investment in its subsidiary, Renal Advanced System Private Limited (RASPL), was revised from capital expenditure to loan repayment. The report also indicates a delay in the utilization of General Corporate Purpose (GCP) proceeds against the expected timeline.